Garheng Kong

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Beth Hecht, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Garheng Kong:

Company Role Class Num Shares Value Price $ Report Date Ownership
LABCORP HOLDINGS INC. Director Common Stock 12,842 $3,017,870 $235.00 06 Feb 2025 Direct
Xeris Biopharma Holdings, Inc. Director Common Stock 214,144 $1,663,898 $7.77 04 Jun 2025 Direct
Venus Concept Inc. Director Voting Convertible Preferred Stock 335,000 $670,000 $2.00 18 Nov 2022 HealthQuest Partners II, L.P.
LABCORP HOLDINGS INC. Director Restricted Stock Unit 897 $220,904 $246.27 11 Feb 2025 Direct
Venus Concept Inc. Director Employee Stock Option (Right to Buy) 75,000 24 Mar 2023 Direct
ALIMERA SCIENCES INC Director Stock Option (Right to Buy) 6,000 04 Jan 2023 Direct
Strongbridge Biopharma plc Director Ordinary Shares 0 $2.06 05 Oct 2021 Direct
Strongbridge Biopharma plc Director Stock Option (Right to Buy) 0 05 Oct 2021 Direct

Insider Reports Filed by Garheng Kong

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XERS Xeris Biopharma Holdings, Inc. 04 Jun 2025 1 $0 4 Director 04 Jun 2025, 18:59
LH LABCORP HOLDINGS INC. 11 Feb 2025 1 $0 4 Director 13 Feb 2025, 08:23
LH LABCORP HOLDINGS INC. 06 Feb 2025 2 $0 4 Director 10 Feb 2025, 08:52
XERS Xeris Biopharma Holdings, Inc. 05 Jun 2024 1 $0 4 Director 05 Jun 2024, 16:18
XERS Xeris Biopharma Holdings, Inc. 15 Mar 2024 1 $0 4 Director 01 Apr 2024, 17:45
LH LABORATORY CORP OF AMERICA HOLDINGS 06 Feb 2024 3 $0 4 Director 08 Feb 2024, 12:47
XERS Xeris Biopharma Holdings, Inc. 07 Jun 2023 1 $0 4 Director 07 Jun 2023, 17:00
VERO Venus Concept Inc. 24 Mar 2023 1 $0 4 Director 28 Mar 2023, 17:59
LH LABORATORY CORP OF AMERICA HOLDINGS 11 Feb 2023 2 $0 4 Director 14 Feb 2023, 14:15
LH LABORATORY CORP OF AMERICA HOLDINGS 07 Feb 2023 1 $0 4 Director 09 Feb 2023, 11:34
/report/000147450623000008-kong-garheng-2023-01-04 ALIMERA SCIENCES INC 04 Jan 2023 1 $0 4 Director 06 Jan 2023, 15:55
VERO Venus Concept Inc. 18 Nov 2022 1 +$670,000 4 Director, 10%+ Owner 22 Nov 2022, 16:14
XERS Xeris Biopharma Holdings, Inc. 08 Jun 2022 2 $0 4 Director 09 Jun 2022, 19:05
VERO Venus Concept Inc. 25 Mar 2022 1 $0 4 Director 28 Mar 2022, 13:25
LH LABORATORY CORP OF AMERICA HOLDINGS 11 Feb 2022 1 $0 4 Director 15 Feb 2022, 11:32
LH LABORATORY CORP OF AMERICA HOLDINGS 02 Feb 2022 2 $0 4 Director 04 Feb 2022, 08:05
VERO Venus Concept Inc. 15 Dec 2021 1 +$2,000,000 4 Director, 10%+ Owner 17 Dec 2021, 15:15
/report/000147450621000164-kong-garheng-2021-11-02 ALIMERA SCIENCES INC 02 Nov 2021 1 $0 4 Director 04 Nov 2021, 21:09
XERS Xeris Biopharma Holdings, Inc. 05 Oct 2021 7 +$46,570 4/A Director 08 Oct 2021, 18:30
/report/000117911021009278-kong-garheng-2021-10-05 Strongbridge Biopharma plc 05 Oct 2021 2 $0 4 Director 06 Oct 2021, 19:41
XERS Xeris Biopharma Holdings, Inc. 05 Oct 2021 0 $0 3 Director 05 Oct 2021, 17:18
/report/000117911021009219-kong-garheng-2021-10-01 Strongbridge Biopharma plc 01 Oct 2021 1 -$36,592 4 Director 05 Oct 2021, 19:22
/report/000117911021005556-kong-garheng-2021-05-18 Strongbridge Biopharma plc 18 May 2021 1 $0 4 Director 18 May 2021, 19:11
/report/000117911021005450-kong-garheng-2021-05-14 Strongbridge Biopharma plc 14 May 2021 1 -$45,120 4 Director 17 May 2021, 19:27